Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lunai Bioworks Inc (LNAI)

Lunai Bioworks Inc (LNAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,929
  • Shares Outstanding, K 24,187
  • Annual Sales, $ 0 K
  • Annual Income, $ -178,010 K
  • EBIT $ -13 M
  • EBITDA $ 157 M
  • 60-Month Beta 0.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.05
  • Most Recent Earnings $-0.08 on 02/17/26
  • Next Earnings Date 05/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 451.76% (+6.24%)
  • Historical Volatility 359.57%
  • IV Percentile 85%
  • IV Rank 39.78%
  • IV High 1,039.55% on 11/06/25
  • IV Low 63.49% on 02/19/26
  • Expected Move (DTE 24) 1.8275 (496.60%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 20
  • Volume Avg (30-Day) 165
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,898
  • Open Int (30-Day) 2,443
  • Expected Range 0.0000 to 2.1955

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1513 +139.52%
on 03/12/26
0.7393 -50.98%
on 03/17/26
-0.0727 (-16.71%)
since 02/24/26
3-Month
0.1513 +139.52%
on 03/12/26
1.1150 -67.50%
on 02/10/26
-0.6236 (-63.25%)
since 12/24/25
52-Week
0.1513 +139.52%
on 03/12/26
7.3380 -95.06%
on 03/25/25
-6.8226 (-94.96%)
since 03/24/25

Most Recent Stories

More News
Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Foundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene Mapping

LNAI : 0.3686 (-10.21%)
Lunai Bioworks: Fiscal Q2 Earnings Snapshot

Lunai Bioworks: Fiscal Q2 Earnings Snapshot

LNAI : 0.3686 (-10.21%)
Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

SACRAMENTO, Calif. , Feb. 13, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute . Company CEO David Weinstein...

LNAI : 0.3686 (-10.21%)
Lunai Bioworks, Inc. Issues Letter to Shareholders

SACRAMENTO, Calif.   , Feb. 9, 2026 /PRNewswire/ --

LNAI : 0.3686 (-10.21%)
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

AI-driven analysis of Phase 2 survival and progression data aims to identify high-benefit patient subgroups and optimize future registrational trial strategy

LNAI : 0.3686 (-10.21%)
Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Transformer-based biosecurity layer embeds directly into foundation models, using Lunai's proprietary toxicology and in-vivo datasets to detect and prevent creation of previously unknown threat agents...

LNAI : 0.3686 (-10.21%)
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

AI Platform Achieves Key Milestones, Triggering Launch of Alcohol Use Disorder Program

LNAI : 0.3686 (-10.21%)
Medical Breakthroughs: 5 AI Innovators Redefining What's Possible

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – The healthcare AI market reached $21.66 billion in 2025 and analysts now project growth to $110.61...

CBLL : 18.92 (-0.42%)
ONMD : 0.8214 (+2.76%)
VPT.VN : 0.115 (unch)
LNAI : 0.3686 (-10.21%)
ABSI : 2.86 (-2.39%)
VPTDF : 0.0857 (+0.82%)
Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

AI-powered drug discovery and biodefense company engages pharma on CNS programs amid rising deal activity

LNAI : 0.3686 (-10.21%)
Financial Pressure Turns Healthcare AI From Pilots Into Profits

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – Healthcare providers shortened buying cycles from eight months to under seven as financial pressures...

VPT.VN : 0.115 (unch)
CCLD : 3.50 (-3.05%)
ABSI : 2.86 (-2.39%)
LNAI : 0.3686 (-10.21%)
CAI : 19.21 (-0.26%)
VPTDF : 0.0857 (+0.82%)

Business Summary

Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 0.5834
2nd Resistance Point 0.5467
1st Resistance Point 0.4786
Last Price 0.3686
1st Support Level 0.3738
2nd Support Level 0.3371
3rd Support Level 0.2690

See More

52-Week High 7.3380
Fibonacci 61.8% 4.5927
Fibonacci 50% 3.7446
Fibonacci 38.2% 2.8966
Last Price 0.3686
52-Week Low 0.1513

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.